Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
This randomized clinical trial examines the safety and efficacy of intravenous alteplase administered 4.5 to 24 hours after stroke onset in patients with salvageable brain tissue.
Related Articles
Prognostic Preferences of Older Adults on Maintenance… : Clinical Journal of the American Society of Nephrology
ed understanding for serious illness conversations, especially for older adults with end stage kidney disease (ESKD). Methods: We conducted a qualitative study of older adults…
Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function
This randomized clinical trial assesses the effect of structured vs self-guided multidomain lifestyle interventions on changes in global cognitive function over 2 years among older…
Nemolizumab for the Treatment of Cholestatic Pruritus in a Liver Transplant Patient with Primary Sclerosing Cholangitis
This case report describes a male individual in his 50s with a history of primary sclerosing cholangitis who had undergone 2 liver transplants and had…
Outcome Monitoring of Mental Health Services in Resource-Limited Countries
This Viewpoint assesses how routine outcomes monitoring can affect mental health outcomes and practitioners’ clinical skills.
Pediatric Intravenous Fluid Use in the Emergency Department During Hurricane Helene
This cross-sectional study explores changes in intravenous fluid use and clinical outcomes of pediatric patients treated in US emergency departments after Hurricane Helene in 2024.
Trends in Labor After Cesarean Delivery Access in the US
This cross-sectional study examines county-level trends in labor after cesarean delivery access across the US from 2016 to 2021.
Gender-Affirming Feminizing Hormone Therapy
This Clinical Insights describes the process for initiating feminizing gender-affirmative hormone therapy for transgender women or nonbinary people.
Breast Cancer Outcomes in Transgender and Gender-Diverse Patients in the National Cancer Database
This cohort study examines breast cancer outcomes in transgender and gender-diverse patients compared with cisgender patients, including overall survival and sociodemographic characteristics.
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.
AJKD Atlas of Renal Pathology: Acute T-Cell–Mediated Rejection
Acute cellular rejection, also called acute T-cell–mediated rejection (TCMR), presents in the transplant recipient with acute kidney injury and decreased urine output, and may be…
